FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Jerald Killion

Research Profile

Living Beings

Anatomy

Tumor Cells, Cultured

Disorders

Neoplasm Metastasis

Chemicals & Drugs

Procedures

Physiology

Phenomena

Phosphorylation

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Sun Jin Kim; Hisanori Uehara; Sertac Yazici; Robert R Langley; Junqin He; Rachel Tsan; Dominic Fan; Jerald J Killion; Isaiah J Fidler
Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
Sachin M Apte; Corazon D Bucana; Jerald J Killion; David M Gershenson; Isaiah J Fidler
Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.
Sachin M Apte; Dominic Fan; Jerald J Killion; Isaiah J Fidler
Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Jerald Killion (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2004: Sun Jin Kim; Hisanori Uehara; Sertac Yazici; Robert R Langley; Junqin He; Rachel Tsan; Dominic Fan; Jerald J Killion; Isaiah J Fidler
Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
Cancer research 2004;64(12):4201-8.
2004: Sachin M Apte; Corazon D Bucana; Jerald J Killion; David M Gershenson; Isaiah J Fidler
Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.
Gynecologic oncology 2004;93(1):78-86.
2004: Sachin M Apte; Dominic Fan; Jerald J Killion; Isaiah J Fidler
Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):897-908.
2003: Rosa F Hwang; Kenji Yokoi; Corazon D Bucana; Rachel Tsan; Jerald J Killion; Douglas B Evans; Isaiah J Fidler
Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6534-44.
2003: Carmen C Solorzano; Rosa F Hwang; Cheryl H Baker; Corazon D Bucana; Peter W T Pisters; Douglas B Evans; Jerald J Killion; Isaiah J Fidler
Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1858-67.
2003: Hisanori Uehara; Sun Jin Kim; Takashi Karashima; David L Shepherd; Dominic Fan; Rachel Tsan; Jerald J Killion; Christopher Logothetis; Paul Mathew; Isaiah J Fidler
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Journal of the National Cancer Institute 2003;95(6):458-70.
2003: Sun-Jin Kim; Hisanori Uehara; Takashi Karashima; David L Shepherd; Jerald J Killion; Isaiah J Fidler
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1200-10.
2002: Daniel Kedar; Cheryl H Baker; Jerald J Killion; Colin P N Dinney; Isaiah J Fidler
Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3592-600.
2002: Samuel F Huang; Sun-Jin Kim; Anh T Lee; Takashi Karashima; Corazon D Bucana; Daniel Kedar; Paul Sweeney; Badar M Mian; Dominic Fan; David Shepherd; Isaiah J Fidler; Colin P N Dinney; Jerald J Killion
Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.
Cancer research 2002;62(20):5720-6.
2002: Jeffrey N Myers; F Christopher Holsinger; B Nebiyou Bekele; Emily Li; Samar A Jasser; Jerald J Killion; Isaiah J Fidler
Targeted molecular therapy for oral cancer with epidermal growth factor receptor blockade: a preliminary report.
Archives of otolaryngology--head & neck surgery 2002;128(8):875-9.
2002: Sean Tedjarati; Cheryl H Baker; Sachin Apte; Suyun Huang; Judith K Wolf; Jerald J Killion; Isaiah J Fidler
Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2413-22.
2001: Carmen C Solorzano; Cheryl H Baker; Christiane J Bruns; Jerald J Killion; Lee M Ellis; J Wood; Isaiah J Fidler
Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.
Cancer biotherapy & radiopharmaceuticals 2001;16(5):359-70.
2001: Carmen C Solorzano; Cheryl H Baker; Rachel Tsan; Peter Traxler; Pinchas Cohen; Elisabeth Buchdunger; Jerald J Killion; Isaiah J Fidler
Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2563-72.
2000: Rakesh Kumar; Keping Xie; I Eue; Zhongyun Dong; Jerald J Killion; Isaiah J Fidler
Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002.
International journal of immunopharmacology 2000;22(6):431-43.
2000: H Shinohara; Corazon D Bucana; Jerald J Killion; Isaiah J Fidler
Intensified regression of colon cancer liver metastases in mice treated with irinotecan and the immunomodulator JBT 3002.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(3):321-31.
2000: S Yano; Roy S Herbst; H Shinohara; B Knighton; Corazon D Bucana; Jerald J Killion; J Wood; Isaiah J Fidler
Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):957-65.
2000: Lei Xu; Junya Yoneda; C Herrera; J Wood; Jerald J Killion; Isaiah J Fidler
Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.
International journal of oncology 2000;16(3):445-54.
2000: Christiane J Bruns; H Shinohara; Matthew T Harbison; Darren W Davis; Gina M Nelkin; Jerald J Killion; David J McConkey; Zhongyun Dong; Isaiah J Fidler
Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages.
Cancer research 2000;60(1):2-7.
1999: H Shinohara; Jerald J Killion; Corazon D Bucana; S Yano; Isaiah J Fidler
Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2148-56.
1999: Junya Yoneda; Jerald J Killion; Corazon D Bucana; Isaiah J Fidler
Angiogenesis and growth of murine colon carcinoma are dependent on infiltrating leukocytes.
Cancer biotherapy & radiopharmaceuticals 1999;14(3):221-30.
1998: Krishnakumar Balasubramanian; Jerald J Killion; Alan J Schroit
Estimation of plasma beta-2-glycoprotein levels by competitive ELISA.
Thrombosis research 1998;92(2):91-7.
1998: I Eue; Rakesh Kumar; Zhongyun Dong; Jerald J Killion; Isaiah J Fidler
Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(5):340-51.
1998: H Shinohara; Jerald J Killion; H Kuniyasu; Rakesh Kumar; Isaiah J Fidler
Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2053-63.
1998: Jerald J Killion; I J Fidler
Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators.
Pharmacology & therapeutics 1998;78(3):141-54.
1998: Zhongyun Dong; Jerald J Killion; Rakesh Kumar; I Eue; X Yang; Weixin Lu; B Su; Isaiah J Fidler
Activation of cytokine production, tumoricidal properties, and tyrosine phosphorylation of MAPKs in human monocytes by a new synthetic lipopeptide, JBT3002.
Journal of leukocyte biology 1998;63(6):766-74.
1998: Michael William Pride; EL Brown; L C Stephens; Jerald J Killion; S J Norris; Margaret L Kripke
Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice.
Journal of leukocyte biology 1998;63(5):542-9.
1998: Jerald J Killion; Robert Radinsky; Isaiah J Fidler
Orthotopic models are necessary to predict therapy of transplantable tumors in mice.
Cancer metastasis reviews 1998;17(3):279-84.
1997: Rakesh Kumar; I Eue; Zhongyun Dong; Jerald J Killion; Isaiah J Fidler
Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JT3002.
Cancer biotherapy & radiopharmaceuticals 1997;12(5):333-40.
1996: Jerald J Killion; Corazon D Bucana; Robert Radinsky; Zhongyun Dong; Terence O'Reilly; G Bilbe; L Tarcsay; Isaiah J Fidler
Maintenance of intestinal epithelium structural integrity and mucosal leukocytes during chemotherapy by oral administration of muramyl tripeptide phosphatidylethanolamine.
Cancer biotherapy & radiopharmaceuticals 1996;11(6):363-71.
1996: Curtis A Pettaway; Sen Pathak; G Greene; E Ramirez; M R Wilson; Jerald J Killion; Isaiah J Fidler
Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(9):1627-36.
1995: Jerald J Killion; P Beltran; Catherine A O'Brian; S S Yoon; Dominic Fan; M R Wilson; Isaiah J Fidler
The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251.
Oncology research 1995;7(9):453-9.
1994: S Tanguay; Corazon D Bucana; M R Wilson; Isaiah J Fidler; Andrew C von Eschenbach; Jerald J Killion
In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A.
Cancer research 1994;54(22):5882-8.
1994: S Tanguay; Jerald J Killion
Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells.
Lymphokine and cytokine research 1994;13(4):259-63.
1994: Jerald J Killion; R Fishbeck; M Bar-Eli; Y Chernajovsky
Delivery of interferon to intracellular pathways by encapsulation of interferon into multilamellar liposomes is independent of the status of interferon receptors.
Cytokine 1994;6(4):443-9.
1994: Jerald J Killion; Isaiah J Fidler
Systemic targeting of liposome-encapsulated immunomodulators to macrophages for treatment of cancer metastasis.
ImmunoMethods 1994;4(3):273-9.
1994: Jerald J Killion; D R Brown; M R Wilson; M M Lloyd; Isaiah J Fidler
Prevention of chemotherapy- or X-irradiation-induced monocytopenia by oral administration of lipophilic muramyl tripeptide.
Oncology research 1994;6(8):357-64.
1993: Jerald J Killion; Robert Radinsky; Zhongyun Dong; R Fishbeck; P Whitworth; Isaiah J Fidler
The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype.
Cancer immunology, immunotherapy : CII 1993;36(6):381-6.
1992: R A Stephenson; Colin P N Dinney; K Gohji; N G Ordóñez; Jerald J Killion; Isaiah J Fidler
Metastatic model for human prostate cancer using orthotopic implantation in nude mice.
Journal of the National Cancer Institute 1992;84(12):951-7.
1992: Colin P N Dinney; T Utsugi; Isaiah J Fidler; Andrew C von Eschenbach; Jerald J Killion
Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferon.
Cancer research 1992;52(5):1155-61.
1992: Jerald J Killion; Eugenie S Kleinerman; M R Wilson; M Tanaka; Isaiah J Fidler
Sequential therapy with chemotherapeutic drugs and liposome-encapsulated muramyl tripeptide: determination of potential interactions between these agents.
Oncology research 1992;4(10):413-8.
1991: T Utsugi; Colin P N Dinney; Jerald J Killion; D Brown; Isaiah J Fidler
In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cells.
Lymphokine and cytokine research 1991;10(6):487-93.
1991: Colin P N Dinney; Corazon D Bucana; T Utsugi; Isaiah J Fidler; Andrew C von Eschenbach; Jerald J Killion
Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
Cancer research 1991;51(14):3741-7.
1991: T Utsugi; Colin P N Dinney; Jerald J Killion; Isaiah J Fidler
In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362.
Cancer immunology, immunotherapy : CII 1991;33(6):375-81.
1990: Dong M Shin; Isaiah J Fidler; C D Bucana; Dominic Fan; Waun Ki Hong; Jerald J Killion
Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line.
Journal of biological response modifiers 1990;9(4):355-60.
1990: D N Frangos; Jerald J Killion; Dominic Fan; R Fishbeck; Andrew C von Eschenbach; Isaiah J Fidler
The development of liposomes containing interferon alpha for the intravesical therapy of human superficial bladder cancer.
The Journal of urology 1990;143(6):1252-6.
1990: Andrew C von Eschenbach; A Avallone; J Price; D Swanson; Jerald J Killion; R Stephenson; I J Fidler
The biology of renal cancer: the influence of nephrectomy.
European urology 1990;18 Suppl 2():40-1.
1989: Jerald J Killion; Dominic Fan; Corazon D Bucana; D N Frangos; Janet E Price; Isaiah J Fidler
Augmentation of antiproliferative activity of interferon alfa against human bladder tumor cell lines by encapsulation of interferon alfa within liposomes.
Journal of the National Cancer Institute 1989;81(18):1387-92.
1989: Jerald J Killion
Modern views of metastasis.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1989;1(1):36-8.
1989: Jerald J Killion; I J Fidler
Mechanisms of cancer metastasis.
Arzneimittel-Forschung 1989;39(8A):1031-4.
1989: Jerald J Killion; Isaiah J Fidler
The biology of tumor metastasis.
Seminars in oncology 1989;16(2):106-15.
1989: Jerald J Killion; I J Fidler
Evasion of host responses in metastasis: implications of cellular resistance to cytokines.
Current opinion in immunology 1989;2(5):693-6.
1989: J W Johnson; R Nayar; Jerald J Killion; A C von Eschenbach; Isaiah J Fidler
Binding of liposomes to human bladder tumor epithelial cell lines: implications for an intravesical drug delivery system for the treatment of bladder cancer.
Selective cancer therapeutics 1989;5(4):147-55.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.